Medical physics – the application of physics principles and techniques to medicine – plays a pivotal role within modern healthcare, with advances in the field serving to improve diagnostic accuracy, treatment precision and patient safety. But despite its immense potential to enhance patient care, medical physics in the UK faces various funding, regulatory and approval challenges that may prevent it from fulfilling this promise.
Taking a closer look at these obstacles, the Institute of Physics (IOP) has published a new community perspective report entitled Medical Physics in the UK: Opportunities and Challenges. The report examines the barriers to translation and commercialization of medical physics research, and proposes the next steps towards creating a more supportive environment for medical physics in the UK.
The report was instigated by the IOP Medical Physics Group and presents the conclusions of a series of discussions, held over two months, examining the challenges that medical physicists encounter in their daily work. The report also highlights the outcomes of an intensive two-day workshop examining the translation of quantum technologies into clinical applications.
The challenges and the opportunities
The UK has a strong legacy of leading medical physics research. To benchmark its contributions, the report authors analysed the top 5% most highly cited papers published in international medical physics journals from 2014 to 2023, revealing that the UK is fourth in the world for its research output in medical physics.
The UK also boasts a large, diverse medical technology industry and has the sixth largest medical device market globally. Notably, its research output involves a high proportion of non-academic co-authors – including corporate, government and clinical collaborators – suggesting a strong potential for translating physics research into the medical market.
The report identifies some of the challenges in realising this potential, including a stretched workforce and critical skills shortages, and outlines some of the more impactful obstacles – namely misaligned funding structures, a complex regulatory landscape, and lengthy approval processes for medical devices and clinical trials.
In the UK, medical physics research is funded by a combination of government agencies, charitable organizations, and independent trusts. The multidisciplinary nature of medical physics, however, risks promising projects falling into the gaps between funding categories, making it difficult for researchers to secure financial backing.
Navigating the regulatory landscape for medical physics developments is also a complex process, with different global markets having their own specific requirements. Challenges here include obtaining initial regulatory approval, adapting to evolving standards and managing multiple regulatory bodies simultaneously. And while new technologies are often sold into larger markets such as the USA and Germany, the UK’s medical device approval process lacks seamless integration with international regulatory bodies, creating barriers to such wider market adoption.
Finally, clinical trials and validation processes for medical physics innovations can often take several years. Securing funding for large-scale trials and collecting sufficient data to demonstrate long-term efficacy can also lead to delays in introducing new technologies to patients.
Imaging and medical-physics firms bag Institute of Physics business awards 2024
Overcoming these challenges will be key to fully exploiting the significant potential of medical physics to revolutionize healthcare in the UK. An initial step could be to bring together this diverse community – including researchers, medical practitioners, industry, NHS officials, government representatives and funders – to initiate a collaborative dialogue and brainstorm innovative strategies.
The report suggests three possible discussion points: how to better align funding mechanisms to support interdisciplinary research; how to shape an integrated regulatory framework with increased transparency; and how to strengthen collaboration between academia, healthcare and industry.
Such discussions should result in a comprehensive list of actionable recommendations. The report authors propose that the IOP establishes an impact project to explore the details of these recommendations and identify pragmatic, implementable solutions for their implementation.
